ARTV insider filings
Artiva Biotherapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-07. Screen ARTV transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 38 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 6 filings by 6 insiders — 540,203 shares, $5,136,282 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 12 legs across 12 filings by 4 insiders — 218,793 shares, $1,997,682 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: purchase of 152,472 shares @ $8.93 ($1,361,575) by RA CAPITAL MANAGEMENT, L.P., filed 2026-07-20.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner & RA Capital Healthcare Fund LP — Director, 10% owner & RA Capital Nexus Fund, L.P. — Director & RA Capital Nexus Fund III, L.P. — Director & Kolchinsky Peter — Director, 10% owner & Shah Rajeev M. — Director, 10% owner | 8 | 11 legs · 540,203 sh · $5,136,282 | — | 2 |
| Aslan Fred — Chief Executive Officer, Director | 6 | — | 4 legs · 170,476 sh · $1,536,845 | 4 |
| Horan Christopher — Chief Tech Operations Officer | 3 | — | 2 legs · 20,706 sh · $186,335 | 2 |
| Bush Jennifer — COO, CLO, Compliance Officer | 3 | — | 2 legs · 16,761 sh · $150,833 | 2 |
| Banerjee Subhashis — Chief Medical Officer | 5 | — | 4 legs · 10,850 sh · $123,669 | 6 |
| Baker Daniel G. — Director | 2 | — | — | 2 |
| DANIELS BRIAN — Director | 2 | — | — | 2 |
| HOUGEN ELIZABETH L — Director | 2 | — | — | 2 |
| MOORE ALISON — Director | 2 | — | — | 2 |
| Miralles Gines Diego — President & Head of R&D | 1 | — | — | 2 |
+2 more insiders in the window, not shown — every filing appears in the table below.
Recent insider filings — Artiva Biotherapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-07 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 23,463 @ $7.20 | EDGAR |
| 2026-10-06 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 61,696 @ $6.84 | EDGAR |
| 2026-10-06 | 4 | Banerjee Subhashis — Chief Medical Officer | Sale (S): 1,099 @ $6.84 | EDGAR |
| 2026-10-06 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Sale (S): 8,370 @ $6.84 | EDGAR |
| 2026-10-06 | 4 | Horan Christopher — Chief Tech Operations Officer | Sale (S): 10,340 @ $6.84 | EDGAR |
| 2026-09-15 | 4 | Aslan Fred — Chief Executive Officer, Director | Grant/award (A): 110,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Aslan Fred — Chief Executive Officer, Director | Grant/award (A): 45,000 @ $0 · Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | MOORE ALISON — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Baker Daniel G. — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | DANIELS BRIAN — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | HOUGEN ELIZABETH L — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Sorg Elaine K. — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | Stoppel Laura — Director | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Miralles Gines Diego — President & Head of R&D | Grant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Banerjee Subhashis — Chief Medical Officer | Grant/award (A): 30,000 @ $0 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Grant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | Horan Christopher — Chief Tech Operations Officer | Grant/award (A): 40,000 @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2026-09-09 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 23,429 @ $10.92 | EDGAR |
| 2026-09-08 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Stoppel Laura — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Baker Daniel G. — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | DANIELS BRIAN — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | HOUGEN ELIZABETH L — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Sorg Elaine K. — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | MOORE ALISON — Director | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-09-04 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 61,888 @ $11.16 | EDGAR |
| 2026-09-04 | 4 | Banerjee Subhashis — Chief Medical Officer | Sale (S): 1,100 @ $11.16 | EDGAR |
| 2026-09-04 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Sale (S): 8,391 @ $11.16 | EDGAR |
| 2026-09-04 | 4 | Horan Christopher — Chief Tech Operations Officer | Sale (S): 10,366 @ $11.16 | EDGAR |
| 2026-08-31 | 4 | Banerjee Subhashis — Chief Medical Officer | Option exercise (M): 5,306 @ $1.92 · Sale (S): 8,222 @ $12.01 · Option exercise (M): 5,306 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Banerjee Subhashis — Chief Medical Officer | Option exercise (M): 429 @ $1.92 · Sale (S): 429 @ $12 · Option exercise (M): 429 (derivative) @ $0 | EDGAR |
| 2026-07-31 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 20,824 @ $9.99 · Purchase (P): 24,944 @ $9.93 | EDGAR |
| 2026-07-28 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 41,319 @ $9.99 | EDGAR |
| 2026-07-23 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 120,582 @ $9.55 · Purchase (P): 84,124 @ $9.93 · Purchase (P): 59,880 @ $9.96 | EDGAR |
| 2026-07-23 | 4/A | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 6,522 @ $8.94 | EDGAR |
| 2026-07-20 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 152,472 @ $8.93 · Purchase (P): 7,882 @ $8.95 | EDGAR |
| 2026-07-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 15,102 @ $8.97 · Purchase (P): 6,552 @ $8.94 | EDGAR |
| 2026-06-29 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 31,000 @ $8.88 · Purchase (P): 1,876 @ $8.98 | EDGAR |
| 2026-06-16 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 391,019 @ $8.57 · Purchase (P): 15,414 @ $8.99 · Purchase (P): 124,893 @ $8.89 | EDGAR |
| 2026-06-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 479,039 @ $6.91 · Purchase (P): 103 @ $7 · Purchase (P): 548,580 @ $7.91 | EDGAR |
| 2026-05-28 | 4 | GC Corp. — 10% owner GC Cell Corp — 10% owner | Purchase (P): 1,085,069 @ $11.52 · Purchase (P): 347,222 @ $11.52 | EDGAR |
| 2026-05-19 | 4 | Raymon Heather — SVP, Research and Development | Sale (S): 3,095 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Banerjee Subhashis — Chief Medical Officer | Sale (S): 7,037 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Aslan Fred — Chief Executive Officer, Director | Sale (S): 27,116 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Miralles Gines Diego — President & Head of R&D | Grant/award (A): 77,500 @ $0 · Grant/award (A): 232,500 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Horan Christopher — Chief Tech Operations Officer | Sale (S): 7,002 @ $9.01 | EDGAR |
| 2026-05-19 | 4 | Bush Jennifer — COO, CLO, Compliance Officer | Sale (S): 8,790 @ $9.01 | EDGAR |
| 2026-05-13 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 6,510,416 @ $11.52 · Purchase (P): 2,170,138 (derivative) @ $11.52 | EDGAR |
| 2026-03-10 | 4 | Huston Thad Allen — Chief Financial Officer | Grant/award (A): 220,000 @ $0 | EDGAR |
Recent 8-K events — Artiva Biotherapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARTV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →